Premium
Osteomyocutaneous flap as a preclinical composite tissue allograft: Swine model
Author(s) -
Ren Xiaoping,
Shirbacheh Mansour V.,
Üstüner E. Tuncay,
Zdichavsky Marty,
Edelstein Jean,
Maldonado Claudio,
Breidenbach Warren C.,
Frank Johannes,
Tobin Gordon R.,
Jones Jon W.,
Barker John H.
Publication year - 2000
Publication title -
microsurgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.031
H-Index - 63
eISSN - 1098-2752
pISSN - 0738-1085
DOI - 10.1002/(sici)1098-2752(2000)20:3<143::aid-micr9>3.0.co;2-9
Subject(s) - medicine , surgery , thrombosis , edema , allotransplantation , infiltration (hvac) , histopathology , microsurgery , biopsy , transplantation , radiology , pathology , physics , thermodynamics
Composite tissue allotransplantation (CTA) constitutes one of the last frontiers of microsurgery. Prior to its clinical application, the long‐term efficacy of modern immunotherapy must be tested in a pre‐clinical CTA model. Based on the concept of osteomyocutaneous forearm flap, we developed a CTA flap model in swine. After identifying the vascular territory of the flaps in six pigs (vascular casting), flaps were transplanted from mismatched donor to recipient pigs (n = 6). Rejection was assessed daily by visual inspection and histopathology of biopsy specimens. Recipient pigs were able to ambulate immediately following surgery. There were no flap failures owing to technical or surgical complications. Rejection occurred over a period of 7 days as manifested by edema, cellular infiltration, epidermalysis, and thrombosis. This pre‐clinical flap model is excellent for evaluating the effectiveness of modern immunotherapy because it is anatomically and immunologically relevant and because the minimal morbidity caused to the animal permits long‐term studies. © 2000 Wiley‐Liss, Inc. MICROSURGERY 20:143–149 2000